A Study of Ritonavir (an Anti-HIV Drug) in HIV-Positive Infants and Children
This study has been completed.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
First received: November 2, 1999
Last updated: October 28, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||January 2004|
|Estimated Primary Completion Date:||No date given|
Gould Chadwick E, Rodman JH, Britto P, Powell C, Palumbo P, Luzuriaga K, Hughes M, Abrams EJ, Flynn PM, Borkowsky W, Yogev R; the PACTG Protocol 345 Team. Ritonavir-Based Highly Active Antiretroviral Therapy in Human Immunodeficiency Virus Type 1-Infected Infants Younger Than 24 Months of Age. Pediatr Infect Dis J. 2005 Sep;24(9):793-800.